1-3 of 3
Stephen B. Linda, MS
Close
Sort by
Journal Articles

A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232

Mignon L Loh, MD, Richard C. Harvey, PhD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Stephen B. Linda, MS, Meenakshi Devidas, PhD, Michael J. Borowitz, MD, PhD, Andrew J. Carroll, PhD, I-Ming Chen, DVM, MS, Julie M. Gastier-Foster, PhD, Nyla A. Heerema, PhD, Huining Kang, PhD, Elizabeth A. Raetz, MD, Kathryn G. Roberts, PhD, Jinghui Zhang, PhD, Naomi Winick, MD, Brent L. Wood, MD, PhD, Eric C. Larsen, MD, William L. Carroll, MD, Cheryl L Willman, MD, Stephen P Hunger, MD
Journal: Blood
Blood (2011) 118 (21): 743.
https://doi.org/10.1182/blood.V118.21.743.743
Published: 2011
Journal Articles

Improved Post-Induction Chemotherapy Does Not Abrogate Prognostic Significance of Minimal Residual Disease (MRD) for Children and Young Adults with High Risk Acute Lymphoblastic Leukemia (ALL). A Report From Children's Oncology Group (COG) Study AALL0232

Michael J. Borowitz, MD, PhD, Brent L. Wood, MD, PhD, Meenakshi Devidas, PhD, Mignon L Loh, MD, Elizabeth A. Raetz, MD, Wanda Salzer, MD, James Nachman, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Julie M. Gastier-Foster, PhD, Cheryl L Willman, MD, Stephen B. Linda, MS, Naomi Winick, MD, Stephen Hunger, MD, William L. Carroll, MD, Eric C. Larsen, MD
Journal: Blood
Blood (2011) 118 (21): 1440.
https://doi.org/10.1182/blood.V118.21.1440.1440
Published: 2011
Journal Articles

Longer Time to the Start of Continuation Therapy Is Associated with Improved Survival In High Risk Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG)

Marla H Daves, MD, Stephen Hunger, MD, Stephen B Linda, MS, W. Paul Bowman, MD, Nita L. Seibel, MD, Lillian Sung, MD, PhD, Meenakshi Devidas, PhD
Journal: Blood
Blood (2010) 116 (21): 3223.
https://doi.org/10.1182/blood.V116.21.3223.3223
Published: 2010